Biobide presented about Toxicity topics for Drug Discovery in Japan
"Testicular Toxicity Assessment using Zebrafish" and "Validation and Qualification of New Alternative Methods (NAMs) for human safety and toxicity testing" have been the topics presented.
What an exciting and fulfilling November week for Arantza Muriana, Biobide R&D Director.
She presented at the Japanese Teratology Society, diving into the topic of "Testicular Toxicity Assessment using Zebrafish", with a focus on Adult Zebrafish Sperm Analysis.
Testicular tox assessment using zebrafish is an emerging method in toxicology studies, taking advantage of the zebrafish's transparency, rapid development, and genetic similarity to humans. This model has become increasingly popular for testing the toxicity of various substances, including pharmaceuticals, environmental chemicals and industrial products.
The other topic presented at the Zebrafish & Medaka-Based Drug Discovery Society 2024 was "Validation and Qualification of New Alternative Methods (NAMs) for human safety and toxicity testing", highlighting how these approaches contribute to reducing animal testing. Her presentation featured case studies of Zebrafish Developmental and Neurodevelopmental assays.
This reflects Biobide's ongoing commitment to advancing zebrafish as a New Alternative Model (NAM), driving innovation and transforming research.